Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBT vs RYOIX overlap: 30% of top holdings shared

Bottom line

How much do FBT and RYOIX overlap?

30% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 31.9% of FBT's assets and 24.2% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.

RYOIX holds far more positions (74 vs 32), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FBTRYOIX
Weight overlap (top 25)30%
Shared holdings10
Weight in shared holdings31.9%24.2%
Total positions3274
Expense ratio0.55%1.38%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings FBT and RYOIX have in common

Holding% of FBT% of RYOIXOverlap
Illumina Inc ILMN3.92%1.94%1.94%
Natera Inc NTRA3.79%2.12%2.12%
Neurocrine Biosciences Inc NBIX3.53%1.52%1.52%
Biogen Inc BIIB3.37%2.13%2.13%
Incyte Corp INCY3.18%1.62%1.62%
Argenx Se ARGX3.13%1.48%1.48%
Vertex Pharmaceuticals Inc VRTX3.07%4.32%3.07%
Amgen Inc AMGN2.78%5.05%2.78%
United Therapeutics Corp UTHR2.56%1.72%1.72%
Alnylam Pharmaceuticals Inc ALNY2.52%2.36%2.36%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBT

  1. Corcept Therapeutics Inc — 5.60%
  2. Neogenomics Inc — 5.12%
  3. Veracyte Inc — 5.10%
  4. Bruker Corp — 4.32%
  5. Alkermes Plc — 4.24%
  6. Krystal Biotech Inc — 3.87%
  7. Axsome Therapeutics Inc — 3.71%
  8. Bio-techne Corp — 3.43%
  9. Arrowhead Pharmaceuticals Inc — 3.38%
  10. Exelixis Inc — 3.32%
  11. Halozyme Therapeutics Inc — 3.11%
  12. Repligen Corp — 3.07%
  13. Biomarin Pharmaceutical Inc — 2.83%
  14. Biontech Se — 2.63%
  15. Genmab A/s — 2.62%

Only in RYOIX

  1. Abbvie Inc — 8.17%
  2. Gilead Sciences Inc — 4.49%
  3. Regeneron Pharmaceuticals Inc — 2.93%
  4. Revolution Medicines Inc — 2.48%
  5. Beone Medicines Ltd — 2.17%
  6. Moderna Inc — 2.15%
  7. Royalty Pharma Plc — 2.01%
  8. Insmed Inc — 1.79%
  9. Guardant Health Inc — 1.72%
  10. Roivant Sciences Ltd — 1.66%
  11. Viatris Inc — 1.55%
  12. Jazz Pharmaceuticals Plc — 1.42%
  13. Bridgebio Pharma Inc — 1.38%
  14. Ionis Pharmaceuticals Inc — 1.35%
  15. Cytokinetics Inc — 1.35%

Asset mix

Asset typeFBTRYOIX
Stocks100.0%99.6%
Repurchase agreements—0.6%
Cash & short-term funds0.1%0.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryFBTRYOIX
US85.0%85.8%
IE4.2%2.7%
CH2.5%3.3%
GB—3.2%
NL3.1%1.5%
DE2.6%1.2%
DK2.6%0.9%
BM—1.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FBT and RYOIX overlap?
About 30% by weight. 10 securities appear in both funds' top 25 holdings; they make up 31.9% of FBT's assets and 24.2% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FBT and RYOIX have in common?
The largest shared holdings are Vertex Pharmaceuticals Inc, Amgen Inc, Alnylam Pharmaceuticals Inc, Biogen Inc, Natera Inc.
Should I own both FBT and RYOIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FBT or RYOIX?
RYOIX is broader, with 74 positions versus 32 for FBT. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.